Freeline TherapeuticsÂ Holdings Plc (FRLN) Peer Comparison

$6.48

$0.00 (0.00%)

As on 29-Feb-2024 09:30EDT

Market cap

$28 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Market cap ($ Mln)	28	181
Revenue ($ Mln)	1	--
Net Profit ($ Mln)	-74.10	-55.86
Net Margin (%)	-11,912.70	-778.31
RoE (%)	-179.73	-23.77
Price to Earnings	--	--
Price-To-Book	0.95	0.81

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Operating Revenue	0.62	0.00
Cost of Revenue	1.74	0.44
Gross Profit	-1.74	-0.44
Operating Expenses	95.29	54.09
Operating Profit (EBIT)	-98.45	-54.09
Other Income	--	3.09
Profit before Tax	-88.60	-50.61
Provision for Tax	0.37	-3.53
Profit after Tax (Net Income)	-88.97	-47.08
Minority Interest	--	--
Consolidated Profit	-140.39	-50.61

Liabilities ($ Mln)

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Shareholder's Funds	52.41	207.62
Minority Interest	--	--
Non-Current Liabilities	3.26	3.70
Current Liabilities	30.97	11.13
Total Liabilities	86.64	222.45

Assets ($ Mln)

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Non-Current Assets	19.01	24.47
Current Assets	67.63	197.98
Total Assets	86.64	222.45
Total Debt*	5.92	3.98
Net Current Assets	36.66	190.99

Cashflow ($ Mln)

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Cash From Operating Activities	-78.22	-32.95
Cash Flow from Investing Activities	-4.27	-117.29
Cash from Financing Activities	27.52	0.18
Net Cash Inflow / Outflow	--	-150.06

Ratios

Profitability Ratios

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
ROCE (%)	-99.53	-20.56
ROE (%)	-102.94	-20.74
ROA (%)	-78.13	-19.89
EBIT Margin (%)	--	--
Net Margin (%)	-14,420.10	-1,522.64
Cash Profit Margin (%)	--	--

Growth Ratios

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Revenue Growth (%)	--	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	36.63	-72.40
EPS Growth (%)	--	-0.60
Book Value Growth (%)	--	--

Valuation Ratios

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Price / Earnings	--	-4.09
Price / Book Value	--	0.93
Dividend Yield (%)	--	--
EV/EBITDA	0.43	0.02
Market Cap ($ Cr)	--	--

Solvency Ratios

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Debt to Equity	0.11	0.02
Short term debt to equity ratio	0.05	0.00
Current Ratio	2.18	17.79
Quick Ratio	1.61	--
Interest Coverage	-9.55	-15.33

Operating Efficiency Ratios

	Freeline TherapeuticsÂ Holdings Plc (FRLN)	Theseus Pharmaceuticals Inc (THRX)
Debtors to sales (%)	199.35	--
Asset Turnover	0.01	0.00
Receivable days	1,018.50	--
Inventory Days	2,525.58	--
Payable days	1,600.14	2,491.29
Cash Conversion Cycle	1,943.94	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly